Shanghai, China – February, 2026 – Innovent Biologics Inc today announced a new strategic collaboration with Eli Lilly…

Indianapolis, IN – February 9, 2026 – Eli Lilly and Company today announced it has entered into a…

AstraZeneca today announced its full-year 2025 results, reflecting continued growth across oncology, cardiovascular-renal-metabolism (CVRM), respiratory & immunology, and…

GSK today reported its full-year performance for 2025 and outlined its strategic approach to long-term growth across vaccines,…

Roche today announced its full-year 2025 performance and outlined its strategic positioning across key therapeutic areas. Roche maintained…

The pharmaceutical market in 2025 was defined by high-value specialty brands delivering breakthrough outcomes in oncology, metabolic disease,…

The global biopharmaceutical industry is entering a new phase in cell therapy innovation, marked by significant investments in…

Pharmaceutical companies are increasingly using artificial intelligence to streamline clinical trials and regulatory filings. While AI has not…

Executive Summary Artificial intelligence has moved from experimental promise to operational backbone across global biopharma. Industry leaders including…